This is the list of companies and organisations who will be attending the European Life Science CEO Forum for Partnering & Investing in Biotech & Pharma Industry, Zurich 09.
| 3i Group |
| 4SC AG |
| Abingworth Management Limited |
| Adamant Biomedical Investments |
| Adamant Ventures |
| Addex Pharmaceuticals Ltd |
| Aescap Venture |
| Agendia |
| Ambrilia Biopharma Inc. |
| Aravis Venture Associates AG |
| Archimedes Pharma Ltd. |
| Atlas Venture |
| Avir Green Hills Biotechnology AG |
| Axentis Pharma AG |
| Axial Biotech, Inc. |
| Baigo Capital GmbH |
| Bank Sarasin & Cie AG |
| BankInvest Biomedical Venture |
| BB Biotech Ventures |
| Bell Pottinger Switzerland |
| Biocrates Life Sciences GmbH |
| BioMedPartners |
| Biotie Therapies Corp. |
| BioXell |
| Bloomberg News |
| Bridgehead International |
| Bristol-Myers Squib |
| Cambridge Consultants Ltd |
| Canaccord Adams |
| Cederberg Advisors |
| Cellerix SA |
| Clinuvel |
| College Hill |
| Credit Suisse |
| DBV Technologies |
| Debiopharm Group |
| Dompé International SA |
| Dresdner Kleinwort |
| DyoDelta Biosciences |
| Edmond de Rothschild Investment Partners |
| Equity Development Ltd. |
| ESBATech AG |
| Esteve Group |
| EVA - the Basel life sciences start-up agency |
| Evolva SA |
| Excellentia Global Partners |
| FCMB Aps |
| FIBREX Medical GmbH |
| Forbion Capital Partners |
| Global Life Science Ventures |
| Global Life Science Ventures AG |
| Green Hills Biotechnology GmbH |
| HBM Partners AG |
| Helsinn Healthcare SA |
| Helvea SA |
| Herbonis AG |
| Hitec Capital SA |
| Hoffmann-La Roche Ltd. |
| immatics biotechnologies GmbH |
| ImVisioN GmbH |
| Index Ventures |
| INVEST SECURITIES |
| Kirchhoff Consult |
| Landsbanki Kepler |
| Lectus Therapeutics Ltd. |
| LifeCycle Pharma A/S |
| Lombard Odier Darier Hentsch & Cie |
| Lumavita AG |
| MC Services |
| Medeor Associates |
| Medicyte GmbH |
| Merck & Co. |
| Merck Serono International S.A. |
| Merck Serono SA |
| Molecular Partners AG |
| MolMed S.p.A |
| Morgan Stanley |
| N.M Rothschild & Sons Ltd |
| Nextech Venture |
| Nitec Pharma AG |
| Novartis International AG |
| Novartis Pharmaceuticals |
| Novo A/S |
| Paul Capital Partners |
| Pfizer, Inc. |
| PharmaVentures Ltd. |
| PharmaWave Ltd |
| PricewaterhouseCoopers AG |
| Pronota N.V. |
| Provecs Medical GmbH |
| PWC Consulting |
| ReNeuron Group plc |
| Roche Venture Fund |
| Rothschild & Cie |
| Sager Pharma Kft. |
| Sal. Oppenheim Jr. & Cie |
| Scil Technology GmbH |
| Selvita Sp. z o.o. |
| SIX Swiss Exchange AG |
| Sofinnova Partners |
| SpinX Technologies |
| Staatz Business Development & Strategy |
| Swiss Biotech |
| Syntaxin Ltd |
| tecData AG |
| Trout Group International LLC |
| Union Bancaire Privée |
| United Technologies AG |
| Ventech |
| Venture Valuation AG |
| VIVUS, Inc. |
| Wilex AG |
| Xceleron Ltd. |
| Xceleron, Inc. |
| Ysios Capital Partners SGECR SA |
| Zürcher Kantonalbank |